Published in J Neurochem on November 01, 2008
Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature (2012) 4.95
Tumor metabolism of lactate: the influence and therapeutic potential for MCT and CD147 regulation. Future Oncol (2010) 1.54
Vascular β-amyloid and early astrocyte alterations impair cerebrovascular function and cerebral metabolism in transgenic arcAβ mice. Acta Neuropathol (2011) 1.02
Resistance to diet-induced obesity and associated metabolic perturbations in haploinsufficient monocarboxylate transporter 1 mice. PLoS One (2013) 0.84
Monocarboxylate transporters in the brain and in cancer. Biochim Biophys Acta (2016) 0.79
Expression and clinical significance of CD147 in renal cell carcinoma: a meta-analysis. Oncotarget (2017) 0.77
The altered glucose metabolism in tumor and a tumor acidic microenvironment associated with extracellular matrix metalloproteinase inducer and monocarboxylate transporters. Oncotarget (2016) 0.75
Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature (2012) 4.95
A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics. Cancer Res (2004) 2.72
Effect of fructose overfeeding and fish oil administration on hepatic de novo lipogenesis and insulin sensitivity in healthy men. Diabetes (2005) 2.43
Monocarboxylate transporters in the central nervous system: distribution, regulation and function. J Neurochem (2005) 2.30
Glial glutamate transporters mediate a functional metabolic crosstalk between neurons and astrocytes in the mouse developing cortex. Neuron (2003) 2.11
N-acetylglucosamine-6-O-sulfotransferases 1 and 2 cooperatively control lymphocyte homing through L-selectin ligand biosynthesis in high endothelial venules. Nat Immunol (2005) 1.91
Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas. Virchows Arch (2008) 1.71
Human dental pulp-derived stem cells promote locomotor recovery after complete transection of the rat spinal cord by multiple neuro-regenerative mechanisms. J Clin Invest (2011) 1.69
Keratan sulfate restricts neural plasticity after spinal cord injury. J Neurosci (2011) 1.63
Lactate is a preferential oxidative energy substrate over glucose for neurons in culture. J Cereb Blood Flow Metab (2003) 1.46
Nuclear targeting by the growth factor midkine. Mol Cell Biol (2002) 1.44
Brain lactate kinetics: Modeling evidence for neuronal lactate uptake upon activation. Proc Natl Acad Sci U S A (2005) 1.42
Transfer of glycogen-derived lactate from astrocytes to axons via specific monocarboxylate transporters supports mouse optic nerve activity. J Neurosci Res (2005) 1.39
GABA uptake into astrocytes is not associated with significant metabolic cost: implications for brain imaging of inhibitory transmission. Proc Natl Acad Sci U S A (2003) 1.33
Hepatic glucose sensing is required to preserve β cell glucose competence. J Clin Invest (2013) 1.27
Mature ovarian cystic teratoma with a highly differentiated homunculus: a case report. Birth Defects Res A Clin Mol Teratol (2004) 1.20
Astrocytes Couple Synaptic Activity to Glucose Utilization in the Brain. News Physiol Sci (1999) 1.20
MCT2 is a major neuronal monocarboxylate transporter in the adult mouse brain. J Cereb Blood Flow Metab (2002) 1.19
A coherent neurobiological framework for functional neuroimaging provided by a model integrating compartmentalized energy metabolism. Proc Natl Acad Sci U S A (2007) 1.18
Competition between glucose and lactate as oxidative energy substrates in both neurons and astrocytes: a comparative NMR study. Eur J Neurosci (2006) 1.17
Midkine plays a protective role against cardiac ischemia/reperfusion injury through a reduction of apoptotic reaction. Circulation (2006) 1.15
Does glutamate image your thoughts? Trends Neurosci (2002) 1.13
Activation of astrocytes by CNTF induces metabolic plasticity and increases resistance to metabolic insults. J Neurosci (2007) 1.11
Combinational antitumor effect of siRNA against midkine and paclitaxel on growth of human prostate cancer xenografts. Cancer (2006) 1.09
Controlled release of small interfering RNA targeting midkine attenuates intimal hyperplasia in vein grafts. J Vasc Surg (2006) 1.08
Ginger ingredients reduce viability of gastric cancer cells via distinct mechanisms. Biochem Biophys Res Commun (2007) 1.07
The growth factor midkine regulates the renin-angiotensin system in mice. J Clin Invest (2009) 1.06
Systemic delivery of siRNA specific to tumor mediated by atelocollagen: combined therapy using siRNA targeting Bcl-xL and cisplatin against prostate cancer. Int J Cancer (2009) 1.05
Midkine is involved in tubulointerstitial inflammation associated with diabetic nephropathy. Lab Invest (2007) 1.05
The neuronal differentiation factor NeuroD1 downregulates the neuronal repellent factor Slit2 expression and promotes cell motility and tumor formation of neuroblastoma. Cancer Res (2011) 1.04
N-acetylglucosamine 6-O-sulfotransferase-1-deficient mice show better functional recovery after spinal cord injury. J Neurosci (2010) 1.03
Comment on recent modeling studies of astrocyte-neuron metabolic interactions. J Cereb Blood Flow Metab (2010) 1.02
N-acetylglucosamine 6-O-sulfotransferase-1 regulates expression of L-selectin ligands and lymphocyte homing. J Biol Chem (2004) 1.01
Selective postsynaptic co-localization of MCT2 with AMPA receptor GluR2/3 subunits at excitatory synapses exhibiting AMPA receptor trafficking. Cereb Cortex (2005) 1.01
Noradrenaline enhances the expression of the neuronal monocarboxylate transporter MCT2 by translational activation via stimulation of PI3K/Akt and the mTOR/S6K pathway. J Neurochem (2007) 1.00
Cell-specific expression pattern of monocarboxylate transporters in astrocytes and neurons observed in different mouse brain cortical cell cultures. J Neurosci Res (2003) 1.00
Effects of flanking genes on the phenotypes of mice deficient in basigin/CD147. Biochem Biophys Res Commun (2004) 1.00
Growth factor midkine is involved in the pathogenesis of diabetic nephropathy. Am J Pathol (2006) 1.00
Preoperative serum midkine concentration is a prognostic marker for esophageal squamous cell carcinoma. Cancer Sci (2003) 0.98
The endogenous proteoglycan-degrading enzyme ADAMTS-4 promotes functional recovery after spinal cord injury. J Neuroinflammation (2012) 0.97
Quantitative rt-PCR analysis of uncoupling protein isoforms in mouse brain cortex: methodological optimization and comparison of expression with brown adipose tissue and skeletal muscle. J Cereb Blood Flow Metab (2004) 0.97
Stimulation-induced increases of astrocytic oxidative metabolism in rats and humans investigated with 1-11C-acetate. J Cereb Blood Flow Metab (2008) 0.97
Unraveling the complex metabolic nature of astrocytes. Front Cell Neurosci (2013) 0.97
Feeding active neurons: (re)emergence of a nursing role for astrocytes. J Physiol Paris (2002) 0.96
Functional analysis of the chondroitin 6-sulfotransferase gene in relation to lymphocyte subpopulations, brain development, and oversulfated chondroitin sulfates. J Biol Chem (2001) 0.96
Lack of the growth factor midkine enhances survival against cisplatin-induced renal damage. Am J Pathol (2004) 0.96
The E-selectin ligand basigin/CD147 is responsible for neutrophil recruitment in renal ischemia/reperfusion. J Am Soc Nephrol (2009) 0.95
Expression of the monocarboxylate transporter MCT1 in the adult human brain cortex. Brain Res (2006) 0.94
Midkine in the pathology of cancer, neural disease, and inflammation. Pathol Int (2012) 0.94
Glucocorticoids modulate neurotransmitter-induced glycogen metabolism in cultured cortical astrocytes. J Neurochem (2004) 0.94
Developmental and hormonal regulation of the monocarboxylate transporter 2 (MCT2) expression in the mouse germ cells. Biol Reprod (2003) 0.94
Potential value of human thrombomodulin and DAF expression for coagulation control in pig-to-human xenotransplantation. Xenotransplantation (2010) 0.93
Midkine antisense oligodeoxyribonucleotide inhibits renal damage induced by ischemic reperfusion. Kidney Int (2005) 0.93
Noradrenaline enhances monocarboxylate transporter 2 expression in cultured mouse cortical neurons via a translational regulation. J Neurochem (2003) 0.93
Differential energetic response of brain vs. skeletal muscle upon glycemic variations in healthy humans. Am J Physiol Regul Integr Comp Physiol (2007) 0.93
The anorexigenic effects of metformin involve increases in hypothalamic leptin receptor expression. Metabolism (2010) 0.93
Paeonol attenuates TNBS-induced colitis by inhibiting NF-kappaB and STAT1 transactivation. Toxicol Appl Pharmacol (2006) 0.92
Measurement of reverse cholesterol transport pathways in humans: in vivo rates of free cholesterol efflux, esterification, and excretion. J Am Heart Assoc (2012) 0.92
Atelocollagen-mediated systemic delivery prevents immunostimulatory adverse effects of siRNA in mammals. Mol Ther (2011) 0.92
EMMPRIN modulates epithelial barrier function through a MMP-mediated occludin cleavage: implications in dry eye disease. Am J Pathol (2011) 0.91
Impact of antithrombin deficiency in thrombogenesis: lipopolysaccharide and stress-induced thrombus formation in heterozygous antithrombin-deficient mice. Blood (2002) 0.91
Midkine promotes neuroblastoma through Notch2 signaling. Cancer Res (2012) 0.91
Metabolic compartmentalization in the human cortex and hippocampus: evidence for a cell- and region-specific localization of lactate dehydrogenase 5 and pyruvate dehydrogenase. BMC Neurosci (2007) 0.91
Insulin and IGF-1 enhance the expression of the neuronal monocarboxylate transporter MCT2 by translational activation via stimulation of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin pathway. Eur J Neurosci (2007) 0.90
High levels of urinary midkine in various cancer patients. Biochem Biophys Res Commun (2003) 0.90
Plasma midkine level is a prognostic factor for human neuroblastoma. Cancer Sci (2008) 0.90
Midkine as a novel target for antibody therapy in osteosarcoma. Biochem Biophys Res Commun (2007) 0.89
Endothelial cell-derived nitric oxide enhances aerobic glycolysis in astrocytes via HIF-1α-mediated target gene activation. J Neurosci (2012) 0.89
Midkine prevents ventricular remodeling and improves long-term survival after myocardial infarction. Am J Physiol Heart Circ Physiol (2008) 0.89
Linking supply to demand: the neuronal monocarboxylate transporter MCT2 and the alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionic acid receptor GluR2/3 subunit are associated in a common trafficking process. Eur J Neurosci (2009) 0.89
Brain energy consumption induced by electrical stimulation promotes systemic glucose uptake. Biol Psychiatry (2011) 0.88
Basigin expression and hormonal regulation in mouse uterus during the peri-implantation period. Mol Reprod Dev (2002) 0.88
Midkine and LDL-receptor-related protein 1 contribute to the anchorage-independent cell growth of cancer cells. J Cell Sci (2007) 0.88
Downregulation of monocyte chemoattractant protein-1 involving short interfering RNA attenuates hapten-induced contact hypersensitivity. Mol Ther (2007) 0.87
Different transcriptional control of metabolism and extracellular matrix in visceral and subcutaneous fat of obese and rimonabant treated mice. PLoS One (2008) 0.87
Disruption of the midkine gene (Mdk) delays degeneration and regeneration in injured peripheral nerve. J Neurosci Res (2009) 0.87
Enhanced expression of three monocarboxylate transporter isoforms in the brain of obese mice. J Physiol (2007) 0.87
Midkine is expressed by infiltrating macrophages in in-stent restenosis in hypercholesterolemic rabbits. J Vasc Surg (2008) 0.86
Dual-gene, dual-cell type therapy against an excitotoxic insult by bolstering neuroenergetics. J Neurosci (2004) 0.86
Midkine gene transfer after myocardial infarction in rats prevents remodelling and ameliorates cardiac dysfunction. Cardiovasc Res (2009) 0.86
N-Acetylglucosamine 6-O-sulfotransferase-1 is required for brain keratan sulfate biosynthesis and glial scar formation after brain injury. Glycobiology (2006) 0.86
5'-,3'-inverted thymidine-modified antisense oligodeoxynucleotide targeting midkine. Its design and application for cancer therapy. J Biol Chem (2002) 0.86
Morpholino antisense oligomer targeting human midkine: its application for cancer therapy. Int J Cancer (2005) 0.85
Cellular distribution of glucose and monocarboxylate transporters in human brain white matter and multiple sclerosis lesions. Glia (2014) 0.85
Brain-derived neurotrophic factor enhances the expression of the monocarboxylate transporter 2 through translational activation in mouse cultured cortical neurons. J Cereb Blood Flow Metab (2009) 0.85
Midkine inhibits inducible regulatory T cell differentiation by suppressing the development of tolerogenic dendritic cells. J Immunol (2012) 0.85
CD44 expression in astrocytes and microglia is associated with ALS progression in a mouse model. Neurosci Lett (2012) 0.85
Premature ligand-receptor interaction during biosynthesis limits the production of growth factor midkine and its receptor LDL receptor-related protein 1. J Biol Chem (2011) 0.84
A2B receptor activation promotes glycogen synthesis in astrocytes through modulation of gene expression. Am J Physiol Cell Physiol (2002) 0.84
Perinatal and early postnatal changes in the expression of monocarboxylate transporters MCT1 and MCT2 in the rat forebrain. J Comp Neurol (2003) 0.84
Enhanced cerebral expression of MCT1 and MCT2 in a rat ischemia model occurs in activated microglial cells. J Cereb Blood Flow Metab (2009) 0.84
Midkine: an emerging target of drug development for treatment of multiple diseases. Br J Pharmacol (2014) 0.84
Increased midkine gene expression in childhood B-precursor acute lymphoblastic leukemia. Leuk Res (2007) 0.84
Increasing whole grain intake as part of prevention and treatment of nonalcoholic Fatty liver disease. Int J Endocrinol (2013) 0.84
Midkine overcomes neurite outgrowth inhibition of chondroitin sulfate proteoglycan without glial activation and promotes functional recovery after spinal cord injury. Neurosci Lett (2013) 0.83
Proteasomal degradation of the nuclear targeting growth factor midkine. J Biol Chem (2004) 0.83
A promoter region of midkine gene can activate transcription of an exogenous suicide gene in human pancreatic cancer. Anticancer Res (2002) 0.83